Press release
Segmentation, Major Trends, and Competitive Overview of the Sterile Compounding Pharmacies Market
Sterile Compounding Pharmacies Market
Growth Projections for the Sterile Compounding Pharmacies Market Through 2030
The sterile compounding pharmacies market size is forecasted to experience robust growth, reaching $7.78 billion by 2030. This expansion is expected at a compound annual growth rate (CAGR) of 6.8%, fueled by the increasing development of biologic drugs, the rise in personalized injectable therapies, limits on hospital capacities, greater adoption of automation technologies, and evolving regulatory standards. Important trends influencing this growth include increased outsourcing of sterile compounding services, advancements in cleanroom technologies, automation of compounding processes, batch-level traceability systems, and investments driven by compliance requirements.
Download a free report of the sterile compounding pharmacies market report:
https://www.thebusinessresearchcompany.com/report/sterile-compounding-pharmacies-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Top Companies Driving the Sterile Compounding Pharmacies Market
Several leading organizations dominate the sterile compounding pharmacies market, such as B. Braun SE, PharMerica Corporation, Fagron Group BV, QuVa Pharma Inc., NewCo Pharma GmbH, Medisca, PharMEDium Healthcare Holdings Inc., Central Admixture Pharmacy Services (CAPS), SandsRx LLC, LeeSar Inc., Avella Specialty Pharmacy, Stokes Pharmacy Inc., Imprimis Pharmaceuticals Inc., Wells Pharmacy Network LLC, McGuff Compounding Pharmacy Services Inc., Potter's House Apothecary Inc., Pharos Innovations LLC, Triangle Compounding Pharmacy Inc., Valor Compounding Pharmacy Inc., Pace Pharmacy, PenCol Specialty Pharmacy LLC, Pavilion Compounding Pharmacy LLC, Olympia Pharmacy, MedisourceRx, Stat RX Pharmacy, Rx3 Compounding Pharmacy, Atlas Pharmaceuticals Co. Ltd., ReNue Rx, Premier Pharmacy Labs Inc., and Absolute Pharmacy Inc.
Strategic Acquisition Expanding Market Reach
In October 2025, Revelation Pharma Corp., a US-based network specializing in compounding pharmacies, acquired Acacia Apothecary & Wellness for an undisclosed amount. This acquisition aims to broaden Revelation Pharma's national network, enhance their sterile and non-sterile compounding capacities, expand their wellness product range, and strengthen their expertise in personalized pharmaceutical solutions. Acacia Apothecary & Wellness is recognized for its focus on customized medications and holistic wellness products within the US market.
View the full sterile compounding pharmacies market report:
https://www.thebusinessresearchcompany.com/report/sterile-compounding-pharmacies-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Technological Advancements Shaping Sterile Compounding Pharmacies
Leading sterile compounding pharmacies are increasingly integrating robotic automation to boost safety, efficiency, and scalability in their operations. These robotic systems include sophisticated monitoring, verification, and labeling features designed to comply with stringent regulatory standards while maintaining high product quality. For example, in March 2023, Omnicell Inc., a healthcare technology firm based in the US, launched IVX Station-a robotic compounding platform for sterile medications operating in an ISO Class 5 cleanroom environment. This system offers continuous environmental monitoring of temperature, humidity, and particles, alongside advanced vision technology, gravimetric verification, automated labeling, and tamper-evident syringe cap application. Additionally, its cloud-based formulation library is regularly updated, facilitating access to the latest authorized formulations and enabling safe, high-volume pharmacy operations.
Segment Breakdown of the Sterile Compounding Pharmacies Market
This report categorizes the sterile compounding pharmacies market into several important segments:
1) By Product Type: Injectables, Nasal, Ocular, Otic
2) By Therapeutic Area: Hormone Replacement Therapy, Pain Management, Dermatology, Oncology, Hematology, Dental, Other Therapeutic Areas
3) By Route of Administration: Intravenous, Intramuscular, Subcutaneous
4) By End-User: Adults, Pediatrics, Geriatrics, Veterinary
Further detailed subsegments include:
- Injectables: Sterile Solutions, Sterile Suspensions, Sterile Powders for Reconstitution
- Nasal: Nasal Sprays, Nasal Solutions, Nasal Gels
- Ocular: Ophthalmic Solutions, Ophthalmic Suspensions, Ocular Inserts
- Otic: Otic Solutions, Otic Suspensions, Otic Gels
This comprehensive segmentation helps provide a clear understanding of the market's diverse product offerings and therapeutic applications, supporting targeted growth strategies and market penetration.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Segmentation, Major Trends, and Competitive Overview of the Sterile Compounding Pharmacies Market here
News-ID: 4486601 • Views: …
More Releases from The Business Research Company
Market Driver Insights: The Impact of Recent Advancements on the Periodontal Dis …
The periodontal disease treatment market is on track for significant expansion in the coming years. With innovations in treatment methods and growing awareness among patients, this sector is preparing to meet increasing demand and evolving healare needs. Let's explore the market's current size, key drivers, prominent players, future trends, and segmentation details to understand the trajectory of this important healare field.
Projected Growth and Market Size of the Periodontal Disease Treatment…
Peptic Ulcer Market Overview: Major Segments, Strategic Developments, and Leadin …
The peptic ulcer market is positioned for consistent advancement as healare innovations and treatment accessibility continue to improve. With ongoing developments in diagnostic tools and therapeutic options, this sector is expected to witness steady expansion over the coming years. Here is a detailed overview of the market's valuation, key players, driving trends, and segment insights shaping its future.
Projected Market Valuation and Growth Trajectory of the Peptic Ulcer Market
The peptic…
Segmentation, Major Trends, and Competitive Overview of the Pelvic Inflammatory …
The pelvic inflammatory disease (PID) treatment market is gearing up for notable expansion in the coming years. With advancements in medical therapies and growing awareness around early diagnosis, this market is set to experience steady growth and evolving treatment strategies. Let's explore the forecasted market size, key players, influential trends, and market segmentation to better understand what lies ahead.
Projected Expansion and Market Size of the Pelvic Inflammatory Disease Treatment Industry…
Leading Companies Fueling Growth and Innovation in the Pediatric Neuroblastoma T …
The pediatric neuroblastoma treatment market is poised for significant expansion as advancements in medical research and technology continue to accelerate. With a focus on innovative therapies and improved patient care, this sector is expected to experience robust growth in the coming years. Below is a detailed overview of the market's size, key players, driving factors, and emerging trends shaping its future.
Pediatric Neuroblastoma Treatment Market Size and Growth Outlook
The market…
More Releases for Pharma
Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva …
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others.
DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…
